Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.

As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...

The collaboration will use Immunai’s single-cell AI platform to identify T-cell targets in cancer and autoimmune diseases.

Abbisko Therapeutics Co., Ltd. on Tuesday announced a new strategic research collaboration and license agreement with Eli ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

VeriSIM Life was founded to solve that problem. The company's core platform, BIOiSIM, is a hybrid mechanistic-AI system that integrates mechanistic quantitative models and machine learning into a ...

The biggest challenge in drug development is that the process is not an even balance of hit or miss – it is overwhelmingly miss, with around 90% of drugs never making it beyond clinical trials. As a ...

Bayer and Iambic Therapeutics Inc., a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, today announced a drug discovery collaboration in ...

Drug development is a complex and time-consuming endeavor that traditionally relies on the experience of drug developers and trial-and-error experimentation. The ...

Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is ...

This Brush Up is sponsored by MilliporeSigma. Learn more about therapeutic synthesis pathways. Drug development is a process that spans many years, from the initial phase of identifying potential drug ...

IQVIA controls one of the world's largest databases of healthcare information that's closely integrated the clinical research ...